Doya Medical

Company Overview

Snapshot

Founded in May 2015 by Galit Avior and Shenfeld Inbal, Doya Medical operates with 1–10 employees. The company has raised $1.5 million across one funding round. In November 2015, Doya Medical secured seed funding.

Business overview

Doya Medical develops noninvasive e-stent technology designed to treat otitis media with effusion, aiming to reduce or eliminate the need for ear tube surgery. Its core product is an active e-stent that drains fluid from the ear naturally, complemented by an optically guided delivery system for insertion into the eustachian tube. The company serves the healthcare industry, targeting hospitals, clinics, and doctors with medical devices and treatments within the Health Tech & Life Sciences sector.

Strategic signal

In April 2018, Doya Medical's development of a non-surgical solution for ear tube surgery in children was highlighted by Globes. This signals the company's focus on innovative, less invasive medical treatments, addressing a significant need in pediatric healthcare and potentially reducing recovery times and medical costs.

Company Intelligence Q&A

What is Doya Medical's primary focus?

Doya Medical focuses on developing a noninvasive e-stent technology to treat otitis media with effusion, aiming to provide a nonsurgical alternative to ear tube surgery.

When was Doya Medical founded?

Doya Medical was founded in May 2015.

Who are the founders of Doya Medical?

Doya Medical was founded by Galit Avior and Shenfeld Inbal.

How much capital has Doya Medical raised?

Doya Medical has raised $1.5 million in total funding.

What significant recognition did Doya Medical receive in 2015?

Doya Medical was a silver winner in the MassChallenge global start-up competition for 2015.